
Beximco Pharmaceuticals Investor Relations Material
Latest events

H1 24/25
28 Jan, 2025

Q1 24/25
15 Nov, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Beximco Pharmaceuticals PLC
Access all reports
Beximco Pharmaceuticals Limited, also known as Beximco Pharma, is a prominent pharmaceutical company based in Bangladesh, part of the Bangladesh Export Import Company Limited (BEXIMCO). Established in 1980, Beximco Pharma has grown to manufacture and market its own branded generics for various diseases including AIDS, cancer, asthma, hypertension, and diabetes, catering to both national and international markets. It holds the distinction of being the first drug company from Bangladesh to sell its products in the US market. The company operates out of its headquarters in Dhanmondi, Dhaka, Bangladesh, and its shares are listed on the Dhaka Stock Exchange and the London Stock Exchange.
Latest articles
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
Ticker symbol
BXP
Country
🇬🇧 United Kingdom